OrthoMTA is ideal for orthograde root canal grafting material especially for file separation, crack tooth syndrome, severely infected canal, and re-endo of acute periapical abscess.…
OrthoMTA is ideal for orthograde root canal grafting material especially for file separation, crack tooth syndrome, severely infected canal, and re-endo of acute periapical abscess. Furthermore, OrthoMTA has a wide variety of clinical indications such as for apexification, repair of root perforations, and internal root resporption.
Who Else Makes It
Concentrated in Shanghai (1), Guangxi (1), Beijing (1).
Record
Regulatory record for OrthoMTA | Listed by | BioMTA, South Korea |
| FDA product code | KIF |
| Device type | Resin, Root Canal Filling |
| Device class | Class 2 |
| Regulation | 21 CFR 872.3820 |
| Establishment | Manufacturer |
| 510(k) | K102575 |
| Record published | 2017-06-22 |
| Record revised | 2024-04-10 (version 4) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Supplied sterile | Yes |
| Single use | Yes |
| Label carries | lot or batch number, expiry date, manufacturing date |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.